Vaginal delivery of bisphosphonates
US6572874B1 · kind B1 · utility
29Cited by
30References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 27, 2000 |
| Grant date | Jun 3, 2003 |
| Priority date | — |
| Expiry date | Jul 27, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Devices, methods, and compositions for vaginal delivery of bisphosphonates. A targeted site delivery of bisphosphonates to the vagina using a medicated intravaginal device comprising a bisphosphonate composition formulated for transvaginal delivery. A method for treatment of osteoporosis and related bone and skeleton diseases, for prevention of bone breakdown and loss of bone mass and strength by intravaginal administration of bisphosphonates to the vagina and transvaginal delivery of bisphosphonates to the general circulation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.